Personal information

No personal information available

Activities

Works (27)

Lung cell entry, cell-cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75.

The Lancet. Infectious diseases
2022-09-15 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann

BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19.

Nature communications
2022-08-18 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann

Long term consequences of COVID-19 and the pandemic (The DEFEnse Against COVID-19 (DEFEAT CORONA) Study protocol): an online-based longitudinal observational study.

JMIR research protocols
2022-08-18 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann
grade
Preferred source (of 2)‎

Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5.

The Lancet. Infectious diseases
2022-06-28 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann

The Impact of COVID-19 Vaccination on the Social Participation of Immunocompromised Persons - Results of a Multicenter Observational Study.

Frontiers in public health
2022-06-10 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann

Immunogenicity of COVID-19 Vaccination in Melanoma Patients under Immune Checkpoint Blockade.

Oncology
2022-05-24 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann

Healthcare Workers' Perceptions and Medically Approved COVID-19 Infection Risk: Understanding the Mental Health Dimension of the Pandemic. A German Hospital Case Study.

Frontiers in public health
2022-05-20 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann

Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2.

Cellular & molecular immunology
2022-05-17 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann

SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies.

Cell host & microbe
2022-05-06 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann

SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study.

BMC infectious diseases
2022-04-25 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann

SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination.

Cell reports
2022-04-15 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann

Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3.

The Lancet. Infectious diseases
2022-04-12 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann

Longitudinal Tracking of Immune Responses in COVID-19 Convalescents Reveals Absence of Neutralization Activity Against Omicron and Staggered Impairment to Other SARS-CoV-2 Variants of Concern.

Frontiers in immunology
2022-03-14 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann

Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination.

Emerging infectious diseases
2022-02-24 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic.

Cell
2021-12-24 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann

Humoral and Cellular Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Human Coronaviruses After Single BNT162b2 Vaccination.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2021-12-01 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann

Long-Lasting Immunity Against SARS-CoV-2: Dream or Reality?

Frontiers in medicine
2021-11-25 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann

Similar humoral immune responses in peritoneal dialysis and haemodialysis patients after two doses of the SARS-CoV-2 vaccine BNT162b2.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis
2021-11-09 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann

Humoral immune response following prime and boost BNT162b2 vaccination in people living with HIV on antiretroviral therapy.

HIV medicine
2021-11-02 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann

The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency.

Cellular & molecular immunology
2021-10-25 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann

SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination.

Lancet (London, England)
2021-08-17 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann

Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis.

EBioMedicine
2021-08-12 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann

Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.

Nature medicine
2021-07-14 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann

[Care of rheumatology patients during the lockdown in early 2020 : Telemedicine, delegation, patient satisfaction and vaccination behavior].

Zeitschrift fur Rheumatologie
2021-05-11 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann

Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods.

Cellular & molecular immunology
2020-11-02 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann

Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals.

Infectious diseases and therapy
2020-09-04 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann

Perceived versus proven SARS-CoV-2-specific immune responses in health-care professionals.

Infection
2020-06-10 | Journal article
Contributors: Anne Cossmann
Source: Self-asserted source
Anne Cossmann